Utah Medical Products
UTMD
93 hedge funds and large institutions have $238M invested in Utah Medical Products in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 9 closing their positions.
33% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 9
27% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 26
3% more funds holding
Funds holding: 90 → 93 (+3)
2.92% more ownership
Funds ownership: 71.07% → 73.99% (+2.9%)
4% less capital invested
Capital invested by funds: $247M → $238M (-$9.01M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.1M |
| 2 |
JP Morgan Chase
New York
|
+$2.62M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.53M |
| 4 |
Millennium Management
New York
|
+$1.88M |
| 5 |
HR
Hayden Royal
Charlotte,
North Carolina
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ProShare Advisors
Bethesda,
Maryland
|
-$11.6M |
| 2 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$848K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$812K |
| 4 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$801K |
| 5 |
KFA
Krane Funds Advisors
New York
|
-$721K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$221K | -2,345 | Closed |
|
|
OAM
102
Oppenheimer Asset Management
New York
| – | -$150K | -1,592 | Closed |
|
UTMD Hedge Fund Activity: Q2 2020 in Review
93 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2020, worth a combined $238M — down 3.6% from $247M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new UTMD positions and 9 closed out — a net gain of 3 holders — while 33 added to existing stakes and 26 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $10.1M. The largest seller was ProShare Advisors, exiting entirely with an estimated $11.6M sold.
- 93 institutional investors held Utah Medical Products (UTMD) as of Q2 2020, up from 90 in Q1 2020.
- Funds reported $238M of Utah Medical Products stock for Q2 2020, down 3.6% quarter-over-quarter.
- 12 funds opened new Utah Medical Products positions in Q2 2020 and 9 closed out, a net change of +3 holders.
- The largest Utah Medical Products buyer in Q2 2020 was Fidelity Investments, an estimated $10.1M added.
- The largest Utah Medical Products seller in Q2 2020 was ProShare Advisors, an estimated $11.6M sold.
Based on aggregated 13F filings for Q2 2020.